News | November 03, 2021
Covaxin shelf-life extended to 12 months from the date of manufacture
This approval of shelf-life extension was based on the availability of additional stability data, which was submitted to CDSCO
This approval of shelf-life extension was based on the availability of additional stability data, which was submitted to CDSCO
_256_384.jpg)
Both parties are expected to invest a total of US $ 1 million to establish the brand
Two leaders in science combine complementary best-in-class technologies for biologics manufacturing customers
Strengthens supply chain continuity with first manufacturing facility outside of the U.S.
It’s the company’s fourth manufacturing site worldwide. Others are located in the US, UK and China
Alnylam is the latest partner in the Medicines Manufacturing Innovation Centre’s third Grand Challenge project, which aims to revolutionise the manufacturing process for oligonucleotide therapies
The applicants will only have to get their Good Manufacturing Practices certification validated every five years to retain their licence
A total of 707 district hospitals across all states and union territories participated in the performance assessment. The Health Management Information System (HMIS) data for the year 2017–18 has been used as a baseline for this exercise
The company will leverage existing hospital and clinic partners’ infrastructure to build specialised `Experience Centres’ and facilitate a seamless, end-to-end secondary care surgery delivery. It will also offer healthcare financing
Lonza, a global manufacturing partner to the pharma, biotech and nutrition industries, has announced it will invest in additional drug product manufacturing capabilities in Switzerland
Subscribe To Our Newsletter & Stay Updated
